IBEX Limited IBEX
44.53
1.31
3.03%
as of 25 Sep
- Market cap
- $573.9M
- P/E
- 13.0×
Follow IBEX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 30.43% | 33.11% | 33.65% | 26.29% |
+8 more TTM periods Free account |
|
| 15.91% | 16.50% | 15.60% | 14.02% | ||
ROIC |
24.66% | 24.45% | 24.28% | 26.13% | |
Return on Tangible Assets |
34.36% | 38.22% | 38.13% | 39.30% | |
Average Days of Receivables |
73.40 | 76.39 | 79.84 | 74.00 | |
Free Cash Flow per Share |
2.33 | 2.40 | 2.17 | 2.33 | |
Free Cash Flow |
31.19 | 32.31 | 29.28 | 31.19 | |
Capital Expenditures |
(27.81) | (29.80) | (29.80) | (22.38) | |
Piotroski F-Score |
7.00 | 7.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
28.86% | 34.98% | 34.47% | 31.91% | |
Accounts Receivable Turnover |
5.19 | 4.89 | 4.61 | 4.96 | |
Accounts Payable Turnover |
21.88 | 22.04 | 18.86 | 17.80 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
18.40 | 17.82 | 21.40 | 23.04 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.15) | (0.16) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.55% | 17.75% | 18.38% | 18.81% | |
Share Based Compensation of Revenue |
1.20% | 1.02% | 1.19% | 1.26% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.27 | 1.32 | 1.33 | 1.29 | |
Depreciation/Fixed assets |
0.49 | 0.43 | 0.40 | 0.47 | |
Capex/Depreciation |
(1.40) | (1.61) | (1.68) | (1.30) | |
Revenue per Share |
48.02 | 46.60 | 44.79 | 43.39 | |
Operating CF per Share |
4.40 | 4.62 | 4.39 | 4.01 | |
Capex per Share |
(2.07) | (2.22) | (2.21) | (1.68) | |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.04 | |
Net Profit Margin |
7.19% | 7.53% | 7.35% | 7.14% |
Columns are period end dates